• Je něco špatně v tomto záznamu ?

Antimicrobial peptide production and plant-based expression systems for medical and agricultural biotechnology

E. Holaskova, P. Galuszka, I. Frebort, MT. Oz,

. 2015 ; 33 (6 Pt 2) : 1005-23. [pub] 20150314

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc16020931

Antimicrobial peptides (AMPs) are vital components of the innate immune system of nearly all living organisms. They generally act in the first line of defense against various pathogenic bacteria, parasites, enveloped viruses and fungi. These low molecular mass peptides are considered prospective therapeutic agents due to their broad-spectrum rapid activity, low cytotoxicity to mammalian cells and unique mode of action which hinders emergence of pathogen resistance. In addition to medical use, AMPs can also be employed for development of innovative approaches for plant protection in agriculture. Conferred disease resistance by AMPs might help us surmount losses in yield, quality and safety of agricultural products due to plant pathogens. Heterologous expression in plant-based systems, also called plant molecular farming, offers cost-effective large-scale production which is regarded as one of the most important factors for clinical or agricultural use of AMPs. This review presents various types of AMPs as well as plant-based platforms ranging from cell suspensions to whole plants employed for peptide production. Although AMP production in plants holds great promises for medicine and agriculture, specific technical limitations regarding product yield, function and stability still remain. Additionally, establishment of particular stable expression systems employing plants or plant tissues generally requires extended time scale for platform development compared to certain other heterologous systems. Therefore, fast and promising tools for evaluation of plant-based expression strategies and assessment of function and stability of the heterologously produced AMPs are critical for molecular farming and plant protection.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020931
003      
CZ-PrNML
005      
20160722121439.0
007      
ta
008      
160722s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.biotechadv.2015.03.007 $2 doi
024    7_
$a 10.1016/j.biotechadv.2015.03.007 $2 doi
035    __
$a (PubMed)25784148
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Holaskova, Edita $u Department of Molecular Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 11, 783 71 Olomouc, Czech Republic. Electronic address: editaa@seznam.cz.
245    10
$a Antimicrobial peptide production and plant-based expression systems for medical and agricultural biotechnology / $c E. Holaskova, P. Galuszka, I. Frebort, MT. Oz,
520    9_
$a Antimicrobial peptides (AMPs) are vital components of the innate immune system of nearly all living organisms. They generally act in the first line of defense against various pathogenic bacteria, parasites, enveloped viruses and fungi. These low molecular mass peptides are considered prospective therapeutic agents due to their broad-spectrum rapid activity, low cytotoxicity to mammalian cells and unique mode of action which hinders emergence of pathogen resistance. In addition to medical use, AMPs can also be employed for development of innovative approaches for plant protection in agriculture. Conferred disease resistance by AMPs might help us surmount losses in yield, quality and safety of agricultural products due to plant pathogens. Heterologous expression in plant-based systems, also called plant molecular farming, offers cost-effective large-scale production which is regarded as one of the most important factors for clinical or agricultural use of AMPs. This review presents various types of AMPs as well as plant-based platforms ranging from cell suspensions to whole plants employed for peptide production. Although AMP production in plants holds great promises for medicine and agriculture, specific technical limitations regarding product yield, function and stability still remain. Additionally, establishment of particular stable expression systems employing plants or plant tissues generally requires extended time scale for platform development compared to certain other heterologous systems. Therefore, fast and promising tools for evaluation of plant-based expression strategies and assessment of function and stability of the heterologously produced AMPs are critical for molecular farming and plant protection.
650    _2
$a zemědělství $x metody $7 D000383
650    _2
$a kationické antimikrobiální peptidy $x biosyntéza $x farmakologie $7 D023181
650    _2
$a biotechnologie $x metody $7 D001709
650    12
$a exprese genu $7 D015870
650    _2
$a rostliny $x metabolismus $7 D010944
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Galuszka, Petr $u Department of Molecular Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 11, 783 71 Olomouc, Czech Republic. Electronic address: petr.galuszka@upol.cz.
700    1_
$a Frebort, Ivo $u Department of Molecular Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 11, 783 71 Olomouc, Czech Republic. Electronic address: ivo.frebort@upol.cz.
700    1_
$a Oz, M Tufan $u Department of Molecular Biology, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 11, 783 71 Olomouc, Czech Republic. Electronic address: tufan.oz@ufl.edu.
773    0_
$w MED00000793 $t Biotechnology advances $x 1873-1899 $g Roč. 33, č. 6 Pt 2 (2015), s. 1005-23
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25784148 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160722121653 $b ABA008
999    __
$a ok $b bmc $g 1155601 $s 945459
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 33 $c 6 Pt 2 $d 1005-23 $e 20150314 $i 1873-1899 $m Biotechnology advances $n Biotechnol Adv $x MED00000793
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace